The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...

Researchers from the Data Science and Artificial Intelligence Institute (DATAI) at the University of Navarra have developed ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...